152 related articles for article (PubMed ID: 8887487)
1. Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library.
Chan SW; Bye JM; Jackson P; Allain JP
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2531-9. PubMed ID: 8887487
[TBL] [Abstract][Full Text] [Related]
2. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.
Zhai W; Davies J; Shang DZ; Chan SW; Allain JP
J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered single-chain Fvs of human immunoglobulin against hepatitis C virus nucleocapsid protein derived from universal phage display library.
Songsivilai S; Dharakul T
Asian Pac J Allergy Immunol; 1998 Mar; 16(1):31-41. PubMed ID: 9681127
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.
Sapparapu G; Planque SA; Nishiyama Y; Foung SK; Paul S
J Biol Chem; 2009 Sep; 284(36):24622-33. PubMed ID: 19542217
[TBL] [Abstract][Full Text] [Related]
6. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human antibodies specific for hepatitis C virus proteins.
Esposito G; Morea V; Scarselli E; Cerino A; Mondelli MU; La Monica N; Traboni C
Arch Virol; 1997; 142(3):601-10. PubMed ID: 9349306
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
[TBL] [Abstract][Full Text] [Related]
9. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient.
Barban V; Fraysse-Corgier S; Paranhos-Baccala G; Petit M; Manin C; Berard Y; Prince AM; Mandrand B; Meulien P
J Gen Virol; 2000 Feb; 81(Pt 2):461-9. PubMed ID: 10644845
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
Tu B; Ziemann RN; Tieman BC; Hawksworth DJ; Tyner J; Scheffel J; Pinkus MS; Brophy SE; Werneke JM; Gutierrez R; White M
Clin Vaccine Immunol; 2010 Jun; 17(6):1040-7. PubMed ID: 20427624
[TBL] [Abstract][Full Text] [Related]
12. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
13. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
Shang D; Zhai W; Allain JP
Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
[TBL] [Abstract][Full Text] [Related]
14. Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase.
Tessmann K; Erhardt A; Häussinger D; Heintges T
J Virol Methods; 2002 May; 103(1):75-88. PubMed ID: 11906735
[TBL] [Abstract][Full Text] [Related]
15. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
17. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
18. [Screening and characterization of human phage antibody to hepatitis C core antigen].
Zhong Y; Cheng J; Shi S; Xia X; Wang G; Yang J; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):217-9. PubMed ID: 11602052
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
20. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
